Immunome IMNM
NASDAQ IMNM
$18.11 +0.19 (+1.06%)
As of: Oct 21, 2026 · 1:54 PM EDT

Immunome (IMNM) FCF Margin (2020 - 2025)

Updated

Immunome's FCF Margin was -2890.13% in FY2025, down 1585.33 percentage points from -1304.80% in FY2024.

Analysis

Immunome (IMNM) FCF Margin (2020 - 2025) Analysis & Trends

  • Per Business Quant data, FCF Margin in earlier years was -1304.80% in FY2024 (-1244.88 pp) and -59.92% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 616.05 Bn 534.58 Bn 17.26 Bn 28.82%
3 AbbVie 500.90 Bn 474.01 Bn 12.70 Bn 18.33%
4 Merck 367.17 Bn 321.54 Bn 12.21 Bn 26.96%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 6.55%
7 Amgen 235.77 Bn 191.17 Bn 7.24 Bn 34.70%
8 Gilead Sciences 190.70 Bn 164.90 Bn 6.22 Bn 44.00%
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn 2.01%
10 Immunome 2.05 Bn 23.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,252.95%
Mar 31, 2025 -1,938.48%
Dec 31, 2024 -1,577.28%
Sep 30, 2024 -1,227.01%
Jun 30, 2024 -1,088.87%
Mar 31, 2024 -1,295.82%
Dec 31, 2023 -465.45%
Sep 30, 2023 -242.64%
Jun 30, 2023 -140.93%
Mar 31, 2023 1,018.06%
Dec 31, 2022 -675,500.00%
Sep 30, 2022 -757,100.00%
Jun 30, 2022 -411,500.00%
Mar 31, 2022 -638,200.00%
Jun 30, 2020 -36,820.00%
API Access

Immunome FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=IMNM&period=max&api_key=YOUR_API_KEY